Montréal, Québec, January 26th, 2009 – Aptilon Corporation (“Aptilon” or the “Corporation”) (TSX-V: APZ), a leader in providing pharmaceutical companies with online sales channels to physicians, today announced that Wayne Musial has joined the company as Senior Vice President, Sales.
Musial has primarily assumed responsibility for sales operations, account management, and client support for the Company's full line of products and services that enable pharmaceutical marketers to create highly cost-effective online sales channels to their target audiences of physicians and health care practitioners. In this newly created role, he will be responsible for Aptilon’s pharmaceutical clients as well as its partners including alliances with digital advertising agencies, pharmaceutical marketing companies, and CLM software vendors.
Musial joined Aptilon from Triple I, a MediMedia company, where he served as Executive Vice-president of Sales & Client Services working with leading US pharmaceutical companies on physician promotion programs across the gamut of personal and electronic media. He previously served at Vice-president of Sales and Customer Service at Synavant, an IMS Health company, where he developed consultative solutions for clients. With over 20 years of experience in sales force technology and marketing, Musial has repeatedly introduced innovative solutions for the pharmaceutical industry.
“Wayne’s experience in helping companies optimize their promotional approaches to target audiences in this very challenging environment will be a key ingredient in Aptilon’s ability to meet the needs of its growing customer base,” said President and Founder, Denis Martineau. “Wayne has a proven track record of delivering double digit growth while building effective client relationships. We are extremely pleased to add a person as respected in the pharmaceutical industry to our leadership team.”
About Aptilon Corporation
Aptilon enables pharmaceutical, biotech and medical device companies to effectively reach and interact with more than 450,000 US physicians via the Internet through its innovative AxcelRxSM Live video detailing platform which hosts promotional, peer selling and other sales and marketing programs. Top ten US pharmaceutical companies have adopted Aptilon’s AxcelRxSM solution to reach leading physicians. Aptilon provides the infrastructure necessary for pharmaceutical companies to build physician awareness, understanding, and product preference during all stages of a product’s life cycle, from pre-launch education through end stage support. For more information, visit www.aptilon.com.
AxcelRxSM and ReachNetSM are service marks of Aptilon Corporation.
Forward-looking statements
This news release contains forward-looking information. These statements relate to future events or future performance and reflect management's current expectations and assumptions. Such forward-looking statements reflect management's current beliefs and are based on information currently available to management of Aptilon. A number of factors could cause actual events, performance or results to differ materially from the events performance and results discussed in the forward-looking statements. These forward-looking statements are made as of the date hereof and Aptilon does not assume any obligation to update or revise them to reflect new events or circumstances.
|
